Related Experiment Video

Updated: Jul 10, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.1K

[Research Progress of BRAF Fusion in Non-small Cell Lung Cancer]

Ping Xiao1, Diansheng Zhong1

  • 1Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|November 21, 2023
PubMed

Insights

BRAF fusions are increasingly detected in non-small cell lung cancer (NSCLC). This review explores clinical features, mechanisms, and treatments for BRAF fusions, aiming to guide future therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) mutations are linked to poor prognosis in advanced non-small cell lung cancer (NSCLC).
  • Current treatments like Dabrafenib plus Trametinib target specific BRAF mutations (e.g., V600E).
  • BRAF fusions, distinct from mutations, are emerging as clinically relevant alterations in NSCLC.

Approach:

  • This review synthesizes current literature on BRAF fusions in NSCLC.
  • It examines the clinical characteristics and oncogenic mechanisms driven by BRAF fusions.
  • The review also discusses existing and potential therapeutic strategies.

Key Points:

  • BRAF fusions represent an alternative oncogenic driver in NSCLC.
  • Understanding the unique biology of BRAF fusions is crucial for effective treatment.
  • There is a significant unmet need for targeted therapies against BRAF fusions.

Conclusions:

  • BRAF fusions require specific diagnostic approaches and tailored therapeutic interventions.
  • Further research into BRAF fusion biology will inform the development of novel treatments.
  • This review provides a foundation for managing NSCLC patients with BRAF fusions.
Keywords:
FusionLung neoplasmsV-Raf murine sarcoma viral oncogene homolog B1

More Related Videos

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.1K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K